12-MONTH OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, SHAM CONTROLLED STUDY EVALUATING A NOVEL DRUG COATED BALLOON FOR THE TREATMENT OF BPH

• D Elterman,
• S Kaplan,
• J Moss,
• S Freedman,
• K Coutinho,
• N Wu,
• M Efros,
• R D’Anna,
• O Padron,
• K Robertson,
• S Lawindy,
• S Mistry,
• N Shore,
• J Spier,
• J Kaminetsky,
• B Mazzarella,
• D Cahn,
• M Jalkut,
• A Te

Affiliations

D Elterman

University of Toronto, Toronto, ON, Canada

S Kaplan

Mount Sinai Health System, New York, NY, USA

J Moss

Oschner LSU Health, Shreveport, LA, USA

S Freedman

Sheldon Freedman Urology, Las Vegas, NV, USA

K Coutinho

New Jersey Urology LLC, Millburn, NJ, USA

N Wu

Comprehensive Urologic Care, Lake Barrington, IL, USA

M Efros

Accumed Research Associates, Garden City, NY, USA

R D’Anna

Arkansas Urology, Little Rock, AR, USA

O Padron

Florida Urology Partners, Tampa, FL, USA

K Robertson

Chesapeake Urology, Hanover, MD, USA

S Lawindy

Advanced Urology Institute, Daytona Beach, FL, USA

S Mistry

North Austin Urology, Austin, TX, USA

N Shore

Carolina Urologic Research Center, Myrtle Beach, SC, USA

J Spier

Rio Grande Urology, El Paso, TX, USA

J Kaminetsky

Manhattan Medical Research Center, New York, NY, USA

B Mazzarella

Urology Austin, Austin, TX, USA

D Cahn

Colorado Clinical Research, Lakewood, CO, USA

M Jalkut

Associated Urologists of North Carolina, Raleigh, NC, USA

A Te

Weill Medical College of Cornell University, New York, NY, USA